BAY 81-8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ≤2 years

  1. Mahlangu, J.
  2. Lopez Fernandez, M.F.
  3. Santagostino, E.
  4. Lalezari, S.
  5. Tseneklidou-Stoeter, D.
  6. Beckmann, H.
  7. Church, N.
Journal:
European Journal of Haematology

ISSN: 1600-0609 0902-4441

Year of publication: 2020

Volume: 104

Issue: 6

Pages: 594-601

Type: Article

DOI: 10.1111/EJH.13402 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals